BioNexus Gene Lab (BGLC) 10-K 2021 FY Annual report

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of the registrant certify, to the best of their knowledge, that the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Form 10-K") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-K, fairly presents, in all material respects, the financial condition and results of operations of the registrant.

	Bionexus Gene Lab Corporation
Dated: March 31, 2022	By:	/s/ Chan Chong Wong
		Chan Chong Wong Chief Executive Officer and Director (Principal Executive Officer)
	By:	/s/ Wei Li Leong
		Wei Li Leong Chief Financial Officer (Principal Financial and Accounting Officer)